BARCLAYS PLC

Position in VOR — Vor Biopharma Inc.

CIK 312069 LONDON, X0

Position in VOR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$268,140

+$265,714 QoQ

Shares Held

14,565

+10609.6% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#73

of 101 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. VOR ranks #209 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$268,140	14,565	+10609.6%	Shares	Defined	2026-08-14
2026-03-31	$2,426	136	-90.3%	Shares	Defined	2026-05-15
2025-12-31	$18,298	1,399	-98.6%	Shares	Sole	2026-02-13
2025-03-31	$71,612	99,739	+804.7%	Shares	Sole	2026-03-17
2024-12-31	$12,236	11,024	0.0%	Shares	Sole	2026-03-19
2024-09-30	$7,716	11,024	-57.2%	Shares	Sole	2026-03-31
2024-06-30	$25,751	25,751	-33.1%	Shares	Sole	2026-03-23
2024-03-31	$91,185	38,475	-26.1%	Shares	Sole	2026-03-24
2023-12-31	$117,180	52,080	+621.0%	Shares	Sole	2026-03-24
2023-09-30	$15,312	7,223	-4.3%	Shares	Sole	2026-03-26
2023-06-30	$23,332	7,551	+144.9%	Shares	Sole	2026-03-27
2022-03-31	$18,621	3,083	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.